Clinical trials
Oropharyngeal Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Marsden NHS Foundation Trust | 2 |
| University of Birmingham | 2 |
| Brynn Chappell | 1 |
| Corbus Pharmaceuticals Inc. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| Inhibrx Biosciences, Inc | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| University College London (UCL) Cancer Institute | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oropharyngeal Neoplasms | 13 |
| Head and Neck Neoplasms | 5 |
| Mouth Neoplasms | 5 |
| Hypopharyngeal Neoplasms | 3 |
| Laryngeal Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Nasopharyngeal Neoplasms | 2 |
| Salivary Gland Neoplasms | 2 |
| Tongue Neoplasms | 2 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.